These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11698457)

  • 1. Rejection of intraocular tumors by CD4(+) T cells without induction of phthisis.
    Schurmans LR; Diehl L; den Boer AT; Sutmuller RP; Boonman ZF; Medema JP; van der Voort EI; Laman J; Melief CJ; Jager MJ; Toes RE
    J Immunol; 2001 Nov; 167(10):5832-7. PubMed ID: 11698457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye.
    Wang S; Boonman ZF; Li HC; He Y; Jager MJ; Toes RE; Niederkorn JY
    J Immunol; 2003 Sep; 171(6):2789-96. PubMed ID: 12960299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T cells circumvent immune privilege in the eye and mediate intraocular tumor rejection by a TNF-alpha-dependent mechanism.
    Dace DS; Chen PW; Niederkorn JY
    J Immunol; 2007 May; 178(10):6115-22. PubMed ID: 17475837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of interferon-γ and cytotoxic T lymphocytes in intraocular tumor rejection.
    Ligocki AJ; Brown JR; Niederkorn JY
    J Leukoc Biol; 2016 May; 99(5):735-47. PubMed ID: 26578649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy promotes indirect elimination of intraocular tumors by CD8+ T cells that is associated with IFNγ- and Fas/FasL-dependent activation of intratumoral macrophages.
    Miller MR; Mandell JB; Beatty KM; Harvey SA; Rizzo MJ; Previte DM; Thorne SH; McKenna KC
    Cancer Immunol Res; 2014 Dec; 2(12):1175-85. PubMed ID: 25248763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner.
    Dace DS; Chen PW; Alizadeh H; Niederkorn JY
    J Leukoc Biol; 2007 Feb; 81(2):421-9. PubMed ID: 17077163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines.
    Chen PW; Ksander BR
    Curr Eye Res; 2006 Jan; 31(1):43-55. PubMed ID: 16421019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Killer T Cells Contribute to Neutrophil Recruitment and Ocular Tissue Damage in a Model of Intraocular Tumor Rejection.
    Ligocki AJ; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):813-23. PubMed ID: 26934137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS; Engelhard VH
    J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI; Brown GR; Thiele DL
    J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors.
    Coursey TG; Chen PW; Niederkorn JY
    Cancer Res; 2011 Apr; 71(7):2445-54. PubMed ID: 21307132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
    Gregory MS; Repp AC; Holhbaum AM; Saff RR; Marshak-Rothstein A; Ksander BR
    J Immunol; 2002 Sep; 169(5):2727-35. PubMed ID: 12193747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages.
    Dace DS; Chen PW; Niederkorn JY
    Immunology; 2008 Mar; 123(3):367-77. PubMed ID: 17944931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo.
    Smyth MJ; Kershaw MH; Trapani JA
    Transplantation; 1997 Apr; 63(8):1171-8. PubMed ID: 9133481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
    Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: perforin down-regulates CD4 and CD8 T cell-mediated immune responses to a transplanted organ.
    Bose A; Inoue Y; Kokko KE; Lakkis FG
    J Immunol; 2003 Feb; 170(4):1611-4. PubMed ID: 12574320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver.
    Liu ZX; Govindarajan S; Okamoto S; Dennert G
    J Immunol; 2001 Mar; 166(5):3035-41. PubMed ID: 11207253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages are vital in spontaneous intraocular tumor eradication.
    Boonman ZF; Schurmans LR; van Rooijen N; Melief CJ; Toes RE; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2959-65. PubMed ID: 16799039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo analysis of adenovirus-specific cytotoxic T lymphocyte response in mice deficient in CD28, fas ligand, and perforin.
    Chen J; Hsu HC; Zajac AJ; Wu Q; Yang P; Xu X; McPherson SA; Li J; Curiel DT; Mountz JD
    Hum Gene Ther; 2006 Jun; 17(6):669-82. PubMed ID: 16776575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.